Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma. (6th November 2014) - Johnson, Laura A; Scholler, John; Ohkuri, Takayuki; Kosaka, Akemi; Patel, Prachi R; McGettigan, Shannon E; Nace, Arben; Thekkat, Pramod; Loew, Andreas; Chen, Taylor J; Fraietta, Joseph A; Posey, Avery D; et al.